Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nkarta
Biotech
Yet another exec departs CRISPR Tx—Chutes & Ladders
Yet another exec departs CRISPR Tx. Aurion CEO replaced after power struggle. Another NIH leader hits the exit.
Darren Incorvaia
,
Zoey Becker
Mar 28, 2025 8:30am
Nkarta lays off 3rd of staff to fund autoimmune CAR NK program
Mar 27, 2025 6:40am
Biopharma largely unfazed by security concerns for JPM25
Jan 17, 2025 11:10am
Nkarta continues pivot to lupus by shelving lymphoma program
Nov 8, 2024 8:55am
How to get cell therapies flying off-the-shelf
May 31, 2024 9:00am
Nkarta's blood cancer CAR stalls again, driving deprioritization
Mar 22, 2024 9:11am
